¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Diffuse mesangial proliferative golmerulonephritis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • mesangial proliferative glomerulonephritis
    Ç÷°ü»çÀÌÁúÁõ½ÄÅ丮ÄáÆÏ¿°, Ç÷°ü°£¼¼Æ÷Áõ½Ä»ç±¸Ã¼½Å¿°
  • diffuse proliferative glomerulonephritis
    ±¤¹üÀ§Áõ½ÄÅ丮ÄáÆÏ¿°, ±¤¹üÀ§Áõ½Ä»ç±¸Ã¼½Å¿°
  • mesangial cell
    Ç÷°ü»çÀ̼¼Æ÷, ¸Þ»êÁö¿ò¼¼Æ÷
  • mesangial matrix
    Ç÷°ü»çÀ̹ÙÅÁÁú, ¸Þ»êÁö¿ò±âÁú
  • exudative proliferative glomerulonephritis
    »ïÃâÁõ½ÄÅ丮ÄáÆÏ¿°, »ïÃâÁõ½Ä»ç±¸Ã¼½Å¿°
  • focal proliferative glomerulonephritis
    ÃÊÁ¡Áõ½ÄÅ丮ÄáÆÏ¿°, ÃÊÁ¡Áõ½Ä»ç±¸Ã¼½Å¿°
  • proliferative arthritis
    Áõ½Ä°üÀý¿°
  • proliferative diabetic retinopathy
    Áõ½Ä´ç´¢¸Á¸·º´(Áõ)
  • proliferative endophlebitis
    Áõ½ÄÁ¤¸Æ³»¸·¿°
  • proliferative fasciitis
    Áõ½Ä±Ù¸·¿°
  • proliferative inflammation
    Áõ½Ä¿°Áõ
  • proliferative retinopathy
    Áõ½Ä¸Á¸·º´(Áõ)
  • proliferative stage
    Áõ½Ä±â
  • proliferative vitreoretinopathy
    Áõ½ÄÀ¯¸®Ã¼¸Á¸·º´(Áõ)
  • degenerative diffuse cerebral sclerosis
    ÅðÇ౤¹üÀ§´ë³ú°æÈ­(Áõ)
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • mesangial proliferative glomerulonephritis
    Ç÷°ü»çÀÌÁúÁõ½ÄÅ丮ÄáÆÏ¿°, Ç÷°ü°£¼¼Æ÷Áõ½Ä»ç±¸Ã¼½Å¿°
  • diffuse goiter
    ±¤¹üÀ§°©»ó»ùÁ¾, ¹Ì¸¸°©»ó»ùÁ¾
  • diffuse esophageal spasm
    ±¤¹üÀ§½Äµµ¿¬Ãà
  • proliferative diabetic retinopathy
    Áõ½Ä´ç´¢¸Á¸·º´Áõ
  • proliferative stage
    Áõ½Ä±â
  • proliferative vitreoretinopathy
    Áõ½ÄÀ¯¸®Ã¼¸Á¸·º´Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • diffuse proliferative glomerulonephritis
    »êÀçÁõ½ÄÅ丮ÄáÆÏ¿°, ¹Ì¸¸Áõ½Ä»ç±¸Ã¼½Å¿°
  • mesangial cell
    Ç÷°ü»çÀ̼¼Æ÷
  • mesangial matrix
    Ç÷°ü»çÀ̹ÙÅÁÁú
  • proliferative arthritis
    Áõ½Ä°üÀý¿°, ·ù¸¶Æ¼½º°üÀý¿°
  • exudative proliferative glomerulonephritis
    »ïÃâÁõ½ÄÅ丮ÄáÆÏ¿°, »ïÃâÁõ½Ä»ç±¸Ã¼½Å¿°
  • proliferative endophlebitis
    Áõ½ÄÁ¤¸Æ³»¸·¿°
  • focal proliferative glomerulonephritis
    ÃÊÁ¡Áõ½ÄÅ丮ÄáÆÏ¿°, ÃÊÁ¡Áõ½Ä»ç±¸Ã¼½Å¿°
  • proliferative fasciitis
    Áõ½Ä±Ù¸·¿°
  • proliferative inflammation
    Áõ½Ä¿°Áõ
  • proliferative retinopathy
    Áõ½Ä¸Á¸·º´Áõ
  • proliferative sparganosis
    Áõ½Ä½ºÆÄ¸£°¡´®Áõ, Áõ½Ä°íÃæÁõ
  • proliferative stage
    Áõ½Ä±â
  • proliferative state
    Áõ½Ä»óÅÂ
  • proliferative vitreoretinopathy
    Áõ½ÄÀ¯¸®Ã¼¸Á¸·º´Áõ
  • proliferative diabetic retinopathy
    Áõ½Ä´ç´¢¸Á¸·º´Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glomerulonephritis,diffuse proliferative
    ¹Ì¸¸¼º Áõ½Ä¼º(ڵؼàõ ñòãÖàõ)
  • Hamman Rich syndrome =diffuse interstitial pulmonary fibrosis
    ÇØ¸Õ- ¸®Ä¡ÁõÈıº.
  • goiter,diffuse nontoxic(simple)
    ¹Ì¸¸¼º ºñµ¶¼º(´Ü¼ø)
  • progressive diffuse keratoderma
    ÁøÇ༺ ±¤¹üÀ§ °¢ÇÇÁõ
  • PVR=>proliferative vitreoretinopathy
    Áõ½ÄÀ¯¸®Ã¼¸Á¸·º´Áõ
  • glomerulonephritis,focal proliferative
    ÃÊÁ¡¼º Áõ½Ä¼º
  • poststreptococcal(proliferative) glomerulonephritis
    ¿¬¼â»ó±¸±Õ°¨¿°ÈÄ(Áõ½Ä¼º) »ç±¸Ã¼½Å¿°(ææáðßÒϹжÊïæøý­(ñòãÖàõ) ÞêϹô÷ãìæú)
  • proliferative arthritis =rheumatoid a.
    Áõ½Ä¼º °üÀý¿° ·ù¸¶Æ¼½º¼º °ü Àý¿° .
  • proliferative arthritis =rheumatoid a.
    Áõ½Ä¼º °üÀý¿°(ñòãÖàõ Î¼ï½æú), ·ù¸¶Æ¼½º¼º °üÀý¿°(¡­Î¼ï½æú)
  • proliferative diabetic retinopathy
    Áõ½Ä´ç´¢¸Á¸·º´Áõ(ñòãÖÓØèñØÑدܻñø).
  • proliferative diabetic retinopathy
    Áõ½Ä¼º ´ç´¢¼º ¸Á¸·º´Áõ(ñòãÖàõ ÓØèñàõ ØÑدܻñø)
  • proliferative endophlebitis
    Áõ½Ä¼º Á¤¸Æ³»¸·¿°(ñòãÖàõ ð¡ØæÒ®Ø¯æú)
  • proliferative glomerulonephritis
    Áõ½Ä¼º »ç±¸Ã¼½Å¿°(ñòãÖàõ ÞêϹô÷ãìæú)
  • proliferative inflammation
    Áõ½Ä¼º ¿°(ñòãÖàõ æú)
  • proliferative phase
    Áõ½Ä±â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glomerulonephritis,diffuse proliferative
    ¹Ì¸¸¼º Áõ½Ä¼º(ڵؼàõ ñòãÖàõ)
  • mesangial cell
    Ç÷°ü»çÀ̼¼Æ÷, Ç÷°ü°£¼¼Æ÷(úìηÊàá¬øà).
  • mesangial cell
    Ç÷°ü»çÀ̼¼Æ÷
  • mesangial matrix
    Ç÷°ü»çÀ̱âÁú, Ç÷°ü°£±âÁú (¡­Ñ¨òõ).
  • mesangial region
    ¸Þ»êÁöÀ½¿µ¿ª.
  • exudative proliferative glomeruloneph
    »ïÃ⼺ Áõ½Ä¼º »ç±¸Ã¼½Å¿°.
  • fasciitis, proliferative
    Áõ½Ä¼º ±Ù¸·¿°.
  • glomerulonephritis,focal proliferative
    ÃÊÁ¡¼º Áõ½Ä¼º
  • poststreptococcal(proliferative) glomerulonephritis
    ¿¬¼â»ó±¸±Õ°¨¿°ÈÄ(Áõ½Ä¼º) »ç±¸Ã¼½Å¿°(ææáðßÒϹжÊïæøý­(ñòãÖàõ) ÞêϹô÷ãìæú)
  • proliferative arthritis =rheumatoid a.
    Áõ½Ä¼º °üÀý¿° ·ù¸¶Æ¼½º¼º °ü Àý¿° .
  • proliferative arthritis =rheumatoid a.
    Áõ½Ä¼º °üÀý¿°(ñòãÖàõ Î¼ï½æú), ·ù¸¶Æ¼½º¼º °üÀý¿°(¡­Î¼ï½æú)
  • proliferative diabetic retinopathy
    Áõ½Ä´ç´¢¸Á¸·º´Áõ(ñòãÖÓØèñØÑدܻñø).
  • proliferative diabetic retinopathy
    Áõ½Ä¼º ´ç´¢¼º ¸Á¸·º´Áõ(ñòãÖàõ ÓØèñàõ ØÑدܻñø)
  • proliferative endophlebitis
    Áõ½Ä¼º Á¤¸Æ³»¸·¿°(ñòãÖàõ ð¡ØæÒ®Ø¯æú)
  • proliferative glomerulonephritis
    Áõ½Ä¼º »ç±¸Ã¼½Å¿°(ñòãÖàõ ÞêϹô÷ãìæú)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Diffuse placenta
    ÆÛÁøÅ¹Ý
    [¿¾ ¿ë¾î] »êÀ缺ŹÝ
  • Mesangial cell
    Ç÷°ü»çÀ̼¼Æ÷
    [¿¾ ¿ë¾î] Ç÷°ü°£¼¼Æ÷
  • Proliferative phase
    Áõ½Ä±â
    [¿¾ ¿ë¾î] Áõ½Ä±â
  • Proliferative state
    Áõ½Ä»óÅÂ
    [¿¾ ¿ë¾î] Áõ½Ä±â
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • proliferative sparganosis
    Áõ½Ä°íÃæÁõ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • proliferative
    Áõ½Ä(¼º)ÀÇ, ¹ø½Ä(¼º)ÀÇ
  • proliferative arthritis
    Áõ½Ä¼º°üÀý¿°
  • diffuse
    ±¤¹ü¼ºÀÇ, ¹Ì¸¸¼ºÀÇ, »êÀ缺ÀÇ
  • diffuse interstitial pneumonia
    ¹Ì¸¸¼º°£Áú¼ºÆó·Å
  • diffuse large cell lymphoma
    ¹Ì¸¸¼º Å«¼¼Æ÷ÀÓÆÄÁ¾
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MPGN Mesangial(Membrano-) Proliferative Glomerulo-Nephritis
MesPGN mesangial proliferative glomerulonephritis
MSPGN mesangial proliferative glomerulonephritis
DMH diffuse mesangial hypercellularity
DMP diffuse mesangial proliferation; dimercaprol; dimethylphthalate
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MesPGN Mesangial proliferative glomerulonephritis
DMS Diffuse mesangial sclerosis
DPGN Diffuse proliferative glomerulonephritis
DPLN Diffuse proliferative lupus nephritis
HMC Human mesangial cell
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • N00.3
    Diffuse mesangial proliferative golmerulonephritis
    ¹Ì¸¸¼º ¸Þ»êÁöÀ½ Áõ½Ä¼º »ç±¸Ã¼½Å¿°
  • N01.3
    Diffuse mesangial proliferative golmerulonephritis
    ¹Ì¸¸¼º ¸Þ»êÁöÀ½ Áõ½Ä¼º »ç±¸Ã¼½Å¿°
  • N02.3
    Diffuse mesangial proliferative golmerulonephritis
    ¹Ì¸¸¼º ¸Þ»êÁöÀ½ Áõ½Ä¼º »ç±¸Ã¼½Å¿°
  • N03.3
    Diffuse mesangial proliferative golmerulonephritis
    ¹Ì¸¸¼º ¸Þ»êÁöÀ½ Áõ½Ä¼º »ç±¸Ã¼½Å¿°
  • N04.3
    Diffuse mesangial proliferative golmerulonephritis
    ¹Ì¸¸¼º ¸Þ»êÁöÀ½ Áõ½Ä¼º »ç±¸Ã¼½Å¿°
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • mesangial matrix
    Ç÷°ü »çÀÌ ±âÁú, Ç÷°ü°£ ±âÁú
  • cellular proliferative layer
    ¼¼Æ÷¼º Áõ½ÄÃþ
    ¼¼Æ÷ÀÇ µ¿ÀÏÇüÅÂÀÇ Àç»ý»ê ¶Ç´Â Áõ½ÄÃþ.
  • focal proliferative glomerulonephritis
    ÃÊÁ¡¼º Áõ½Ä¼º »ç±¸Ã¼ ½Å¿°
  • proliferative
    Áõ½ÄÀÇ, Áõ½Ä¼ºÀÇ, ¹ø½ÄÀÇ, ¹ø½Ä¼ºÀÇ
  • proliferative growth
    Áõ½Ä¼º ¼ºÀå
  • proliferative zone
    Áõ½Ä´ë
  • chronic diffuse sclerosing osteomyelitis
    ¸¸¼º ¹Ì¸¸¼º °æÈ­¼º °ñ¼ö¿°
    ¹Ì¸¸¼ºÀÇ Ä¡ÃßÁúȯ¿¡ ÀÇÇÑ °¨¿°¿¡¼­ ºñ·ÔµÈ´Ù. ³·Àº Á¤µµÀÇ °¨¿°¿¡ ´ëÇÑ °ñÀÇ Áõ½Ä¼º ¹ÝÀÀÀÌ´Ù. ³ë³âÃþÀÇ ¹«Ä¡¾Ç ºÎÀ§¿¡ ÁÖ·Î »ý±ä´Ù. Ưº°ÇÑ ¼Ò°ßÀº ¾ø´Ù. °ñÀÇ ¹Ì¸¸¼º °æÈ­°¡ ½ÉÇÏ°í ¾çÃø¼ºÀÌ´Ù. °æ°è´Â ºÒ¸í·áÇÏ´Ù. Á¶Á÷º´¸®ÇÐÀû ¼Ò°ßÀº Á¶¹ÐÇÏ°í ºÒ±ÔÄ¢ÇÑ °ñ¼ö, ¼¶À¯¼º °ñ¼ö°­ÀÌ´Ù.
  • diffuse
    ±¤¹ü¼ºÀÇ, ¹Ì¸¸¼ºÀÇ, »êÀ缺ÀÇ, ¹Ì¸¸¼º
    ¸íÈ®È÷ °æ°èÁö¿ö Áö°Å³ª ±¹ÇѵÇÁö ¾Ê°í ³Ð°Ô ÆÛÁ®ÀÖ´Â.
  • diffuse aneurysm
    ±¤¹üÀ§ µ¿¸Æ·ù
    µ¿ÀǾî=consecutive aneurysm.
  • diffuse atrophy of alveolar bone
    ¹Ì¸¸¼º Ä¡Á¶°ñ À§Ãà
  • diffuse cortical necrosis
    ¹Ì¸¸¼º ÇÇÁú ±«»ç
  • diffuse epithelial clouding
    ¹Ì¸¸¼º »óÇÇ È¥Å¹
  • diffuse gingival mass
    ¹Ì¸¸¼º Ä¡Àº Á¾¾ç
  • diffuse hemorrhagic syndrome
    ¹Ì¸¸¼º ÃâÇ÷¼º ÁõÈıº
  • diffuse intravascular coagulation
    ¹ü¹ß¼º Ç÷°ü³» ÀÀ°í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
mesangial proliferative glomerulonephritis <nephrology, pathology> Inflammation of the kidney glomerulus (blood filtering portion of the kidney) due to the abnormal deposition of IgM antibody in the mesangium layer of the glomerular capillary. A form of glomerulonephritis that appears to be caused by an abnormal immune response. This disorder generally manifests as nephrotic syndrome.
Symptoms include swelling, dark urine, weight gain, hypertension, anorexia and bloody urine.
Acronym: MPGN
(05 Jan 1998)
diffuse mesangial proliferation <nephrology, pathology> Inflammation of the kidney glomerulus (blood filtering portion of the kidney) due to the abnormal deposition of IgM antibody in the mesangium layer of the glomerular capillary. A form of glomerulonephritis that appears to be caused by an abnormal immune response. This disorder generally manifests as nephrotic syndrome.
Symptoms include swelling, dark urine, weight gain, hypertension, anorexia and bloody urine.
Acronym: MPGN
(05 Jan 1998)
mesangial Referring to the mesangium.
(05 Mar 2000)
mesangial cell <pathology> Cells found within the glomerular lobules of mammalian kidney, where they serve as structural supports, may regulate blood flow, are phagocytic and may act as accessory cells, presenting antigen in immune responses.
(18 Nov 1997)
mesangial nephritis Glomerulonephritis with an increase in glomerular mesangial cells or matrix, or mesangial deposits.
(05 Mar 2000)
vitreoretinopathy, proliferative Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.
(12 Dec 1998)
proliferative Proliferous
Increasing the numbers of similar forms.
(05 Mar 2000)
proliferative arthritis Rarely used term for rheumatoid arthritis, based on the characteristic proliferation of the synovial membrane seen in joints affected by the disease.
(05 Mar 2000)
proliferative bronchiolitis Bronchiolitis with obliteration of bronchiolar lumen and alveoli by epithelial proliferation, which may follow influenza and giant-cell pneumonia.
(05 Mar 2000)
proliferative choroiditis The dense scar tissue produced by severe choroiditis.
(05 Mar 2000)
proliferative dermatitis An infectious exudative dermatitis of cattle, sheep, goats, horses, and other animals (occasionally man) caused by Dermatophilus congolensis; severe (sometimes fatal) dermatophilosis is seen in cattle in the Caribbean, invariable in association with Amblyomma variegatum infestations.
Synonym: proliferative dermatitis, streptothrichosis, streptotrichiasis, streptotrichosis.
(05 Mar 2000)
proliferative fasciitis A benign rapidly-growing subcutaneous nodule characterised by proliferation of fibroblasts and basophilic giant cells slightly resembling ganglion cells.
(05 Mar 2000)
proliferative gingivitis Inflammatory changes in the gingiva characterised by proliferation of the gingival components.
(05 Mar 2000)
proliferative glomerulonephritis Glomerulonephritis with hypercellularity of glomeruli due to proliferation of endothelial or mesangial cells, occurring in acute glomerulonephritis and membranoproliferative glomerulonephritis.
(05 Mar 2000)
proliferative inflammation An inflammatory reaction in which the distinguishing feature is an actual increase in the number of tissue cells, especially the reticuloendothelial macrophages, in contrast to cells exuded from blood vessels; in addition, exudates of various types are likely to be observed in granulomas and other forms of proliferative inflammation, but the latter may occur without an exudate being formed (as in certain infections caused by virus).
Synonym: hyperplastic inflammation.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • diffuse
    È®»ê½ÃŰ´Ù; º¸±Þ½ÃŰ´Ù; »ê¸¸ÇÑ
  • diffuse
    ¹ß»êÇÏ´Ù;À¯Æ÷½ÃŰ´Ù;ÆÛÁø;À¯Æ÷ÇÑ;»ê¸¸ÇÑ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á